These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27887689)

  • 1. Usefulness of Post-coronary Dilation to Prevent Recurrent Myocardial Infarction in Patients Treated With Percutaneous Coronary Intervention for Acute Coronary Syndrome (from the BASE ACS Trial).
    Karjalainen PP; Niemelä M; Laine M; Airaksinen JK; Ylitalo A; Nammas W
    Am J Cardiol; 2017 Feb; 119(3):345-350. PubMed ID: 27887689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE ACS randomized controlled trial: Bioactive versus everolimus-eluting stents in elderly patients.
    Nammas W; de Belder A; Niemelä M; Sia J; Romppanen H; Laine M; Karjalainen PP
    Eur J Intern Med; 2017 Jan; 37():43-48. PubMed ID: 27499178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial.
    Romppanen H; Nammas W; Kervinen K; Mikkelsson J; Pietilä M; Lalmand J; Rivero-Crespo F; Pentikäinen M; Tedjokusumo P; Karjalainen PP
    Minerva Cardioangiol; 2013 Apr; 61(2):201-9. PubMed ID: 23492603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of early percutaneous coronary intervention in diabetic patients with acute coronary syndrome: insights from the BASE ACS trial.
    Karjalainen PP; Airaksinen JK; de Belder A; Romppanen H; Kervinen K; Sia J; Laine M; Nammas W
    Ann Med; 2016 Aug; 48(5):376-83. PubMed ID: 27238465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcome of titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome: Final report of the BASE ACS trial.
    Karjalainen PP; Nammas W; Ylitalo A; de Bruyne B; Lalmand J; de Belder A; Rivero-Crespo F; Kervinen K; Airaksinen JKE
    Int J Cardiol; 2016 Nov; 222():275-280. PubMed ID: 27497110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-based analysis of randomized comparison of bioactive versus everolimus-eluting stents in acute coronary syndrome.
    Sia J; Nammas W; Niemelä M; Airaksinen JK; Lalmand J; Laine M; Tedjokusumo P; Nyman K; Biancari F; Karjalainen PP
    J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):197-203. PubMed ID: 25003998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Preexisting Vascular Disease on the Outcome of Patients With Acute Coronary Syndrome: Insights From the Comparison of Bioactive Stent to the Everolimus-Eluting Stent in Acute Coronary Syndrome Trial.
    Nammas W; Airaksinen JKE; Romppanen H; Sia J; de Belder A; Karjalainen PP
    Angiology; 2017 Jul; 68(6):513-518. PubMed ID: 27543565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Year outcome of bioactive stents versus everolimus-eluting stents in acute coronary syndrome.
    Karjalainen PP; Niemelä M; Pietilä M; Sia J; de Belder A; Rivero-Crespo F; de Bruyne B; Nammas W
    Scand Cardiovasc J; 2016 Aug; 50(4):218-23. PubMed ID: 27102382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Calcified Target Lesions on the Outcome of Percutaneous Coronary Intervention for Acute Coronary Syndrome: Insights From the BASE ACS Trial.
    Karjalainen PP; Nammas W; Kervinen K; de Belder A; Rivero-Crespo F; Ylitalo A; Airaksinen JK
    J Interv Cardiol; 2017 Apr; 30(2):114-123. PubMed ID: 27925308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Titanium-Nitride-Oxide-Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome: The Randomized TIDES-ACS Trial.
    Tonino PAL; Pijls NHJ; Collet C; Nammas W; Van der Heyden J; Romppanen H; Kervinen K; Airaksinen JKE; Sia J; Lalmand J; Frambach P; Penaranda AS; De Bruyne B; Karjalainen PP;
    JACC Cardiovasc Interv; 2020 Jul; 13(14):1697-1705. PubMed ID: 32703593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial.
    Tuomainen PO; Ylitalo A; Niemelä M; Kervinen K; Pietilä M; Sia J; Nyman K; Nammas W; Airaksinen KE; Karjalainen PP
    Int J Cardiol; 2013 Sep; 168(2):1214-9. PubMed ID: 23218575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Titanium-Nitride-Oxide-Coated vs Everolimus-Eluting Stents in Acute Coronary Syndrome: 5-Year Clinical Outcomes of the TIDES-ACS Randomized Clinical Trial.
    Bouisset F; Sia J; Mizukami T; Karjalainen PP; Tonino PAL; Pijls NHJ; Van der Heyden J; Romppanen H; Kervinen K; Airaksinen JKE; Lalmand J; Frambach P; Roza da Costa B; Collet C; De Bruyne B;
    JAMA Cardiol; 2023 Jul; 8(7):703-708. PubMed ID: 37203243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    Giustino G; Harari R; Baber U; Sartori S; Stone GW; Leon MB; Windecker S; Serruys PW; Kastrati A; Von Birgelen C; Kimura T; Stefanini GG; Dangas GD; Wijns W; Steg PG; Morice MC; Camenzind E; Weisz G; Smits PC; Sorrentino S; Sharma M; Farhan S; Faggioni M; Kandzari D; Galatius S; Jeger RV; Valgimigli M; Itchhaporia D; Mehta L; Kim HS; Chieffo A; Mehran R
    JAMA Cardiol; 2017 Aug; 2(8):855-862. PubMed ID: 28658478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) Trials.
    Planer D; Smits PC; Kereiakes DJ; Kedhi E; Fahy M; Xu K; Serruys PW; Stone GW
    JACC Cardiovasc Interv; 2011 Oct; 4(10):1104-15. PubMed ID: 22017936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pooled analysis of two randomized trials comparing titanium-nitride-oxide-coated stent versus drug-eluting stent in STEMI.
    Tuomainen PO; Sia J; Nammas W; Niemelä M; Airaksinen JK; Biancari F; Karjalainen PP
    Rev Esp Cardiol (Engl Ed); 2014 Jul; 67(7):531-7. PubMed ID: 24952392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and efficacy of second-generation everolimus-eluting stents compared to other limus-eluting stents and bare metal stents in patients with acute coronary syndrome.
    Omar A; Torguson R; Kitabata H; Pendyala LK; Loh JP; Magalhaes MA; Satler LF; Suddath WO; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1053-60. PubMed ID: 24619969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stent-oriented versus patient-oriented outcome in patients undergoing early percutaneous coronary intervention for acute coronary syndrome: 2-year report from the BASE-ACS trial.
    Romppanen H; Nammas W; Kervinen K; Airaksinen JK; Pietilä M; Rivero-Crespo F; Debelder A; Tedjokusumo P; Mikkelsson J; Ylitalo A; Karjalainen PP
    Ann Med; 2013 Nov; 45(7):488-93. PubMed ID: 24032547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registry.
    Imori Y; D'Ascenzo F; Gori T; Münzel T; Fabrizio U; Campo G; Cerrato E; Napp LC; Iannaccone M; Ghadri JR; Kazemian E; Binder RK; Jaguszewski M; Csordas A; Capasso P; Biscaglia S; Conrotto F; Varbella F; Garbo R; Gaita F; Erne P; Lüscher TF; Moretti C; Frangieh AH; Templin C
    Cardiol J; 2016; 23(4):374-83. PubMed ID: 27515481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial.
    Hofma SH; Brouwer J; Velders MA; van't Hof AW; Smits PC; Queré M; de Vries CJ; van Boven AJ
    J Am Coll Cardiol; 2012 Jul; 60(5):381-7. PubMed ID: 22835668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.